Intuitive Surgical, Inc. $ISRG Shares Bought by Inscription Capital LLC

Inscription Capital LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 222.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,226 shares of the medical equipment provider’s stock after buying an additional 1,536 shares during the period. Inscription Capital LLC’s holdings in Intuitive Surgical were worth $996,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of ISRG. SteelPeak Wealth LLC lifted its holdings in shares of Intuitive Surgical by 28.7% during the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after buying an additional 9,364 shares during the last quarter. Eastover Investment Advisors LLC raised its position in Intuitive Surgical by 204.8% during the second quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock valued at $7,153,000 after acquiring an additional 8,844 shares in the last quarter. Amalgamated Bank lifted its stake in Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after acquiring an additional 1,772 shares during the last quarter. Bessemer Group Inc. grew its position in Intuitive Surgical by 89.3% in the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after acquiring an additional 371,806 shares in the last quarter. Finally, Sax Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 218.1% during the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock worth $1,334,000 after purchasing an additional 1,684 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 28,800 shares of the firm’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the completion of the transaction, the insider directly owned 27,027 shares of the company’s stock, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the sale, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 114,007 shares of company stock valued at $63,533,844 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on ISRG. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Daiwa Capital Markets increased their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Leerink Partners boosted their target price on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Finally, Evercore ISI set a $580.00 price objective on shares of Intuitive Surgical in a research note on Monday, January 5th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $622.17.

Intuitive Surgical Stock Down 1.4%

ISRG stock opened at $527.44 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market cap of $189.08 billion, a PE ratio of 69.77, a price-to-earnings-growth ratio of 4.35 and a beta of 1.67. The business’s 50-day simple moving average is $564.60 and its 200 day simple moving average is $511.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter last year, the company earned $1.84 EPS. The company’s quarterly revenue was up 22.9% on a year-over-year basis. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.